Two New Biotechs Spin Out From Edinburgh’s Regenerative Medicine Centre
Separate Investments From Syncona and SV Health Investors
Executive Summary
Scotland’s investment in regenerative medicine is paying off with two promising start-ups, one targeting liver disease, the other oncology, launching within days of each other.